CY1114493T1 - Διαδικασια για την παρασκευη μιας ενωσης χρησιμης ως αναστολεα της tafia - Google Patents

Διαδικασια για την παρασκευη μιας ενωσης χρησιμης ως αναστολεα της tafia

Info

Publication number
CY1114493T1
CY1114493T1 CY20131100888T CY131100888T CY1114493T1 CY 1114493 T1 CY1114493 T1 CY 1114493T1 CY 20131100888 T CY20131100888 T CY 20131100888T CY 131100888 T CY131100888 T CY 131100888T CY 1114493 T1 CY1114493 T1 CY 1114493T1
Authority
CY
Cyprus
Prior art keywords
preparation
tafia
suspender
procedure
union used
Prior art date
Application number
CY20131100888T
Other languages
English (en)
Inventor
Kai Rossen
Volker Kraft
Hermut Wehlan
Antony Bigot
Véronique Crocq-Stuerga
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of CY1114493T1 publication Critical patent/CY1114493T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με μια διαδικασία για την παρασκευή μιας ένωσης του χημικού τύπου (Ι), η οποία περιλαμβάνει μια ένωση του χημικού τύπου (IV) με έναν διεστέρα οξαλικού οξέος και με νέες ενδιάμεσες ενώσεις που χρησιμοποιούνται εκεί.
CY20131100888T 2009-05-15 2013-10-09 Διαδικασια για την παρασκευη μιας ενωσης χρησιμης ως αναστολεα της tafia CY1114493T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09290366 2009-05-15
EP10721758.0A EP2430002B1 (en) 2009-05-15 2010-05-11 Process for the preparation of a compound useful as an inhibitor of tafia

Publications (1)

Publication Number Publication Date
CY1114493T1 true CY1114493T1 (el) 2016-10-05

Family

ID=41259362

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100888T CY1114493T1 (el) 2009-05-15 2013-10-09 Διαδικασια για την παρασκευη μιας ενωσης χρησιμης ως αναστολεα της tafia

Country Status (22)

Country Link
US (1) US8865906B2 (el)
EP (1) EP2430002B1 (el)
JP (1) JP5706397B2 (el)
KR (1) KR20120016651A (el)
CN (1) CN102459192B (el)
AU (1) AU2010247431B2 (el)
BR (1) BRPI1010571A2 (el)
CA (1) CA2760748A1 (el)
CY (1) CY1114493T1 (el)
DK (1) DK2430002T3 (el)
ES (1) ES2431068T3 (el)
HR (1) HRP20130881T1 (el)
IL (1) IL216202A (el)
MX (1) MX2011011849A (el)
MY (1) MY157304A (el)
PL (1) PL2430002T3 (el)
PT (1) PT2430002E (el)
RS (1) RS52963B (el)
RU (1) RU2538506C2 (el)
SG (1) SG176558A1 (el)
SI (1) SI2430002T1 (el)
WO (1) WO2010130718A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2548871T3 (da) * 2010-03-18 2017-11-06 Daiichi Sankyo Co Ltd Cycloalkylsubstitueret imidazolderivat
KR20130006620A (ko) * 2010-03-18 2013-01-17 다이이찌 산쿄 가부시키가이샤 시클로프로판카르복실산 유도체
MX2013004193A (es) 2010-11-11 2013-06-05 Sanofi Sa Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.
EP2782575B1 (en) 2011-11-25 2016-04-20 Sanofi Crystalline salts of r)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1h-imidazol-4-yl)-propionic acid
EP2782576B1 (en) 2011-11-25 2016-05-18 Sanofi Sodium salt of (r)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1h-imidazol-4-yl)-propionic acid
EP3184095A1 (en) 2013-05-23 2017-06-28 IP Gesellschaft für Management mbH Administration units comprising polymorph 1 of 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide
ES2965478T3 (es) * 2017-03-01 2024-04-15 Boehringer Ingelheim Int Protodescarboxilación catalizada por metales de transición de derivados del ácido alfa-halo-acrílico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216218A (en) * 1979-02-23 1980-08-05 American Hoechst Corporation Antidepressant and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
IT1177017B (it) * 1984-10-22 1987-08-26 Ravizza Spa Processo per la preparazione dell'acido 2(4-flurofenil)alfa-metil-5-benzox azoloacetico
HUP0104657A3 (en) * 1998-12-24 2002-07-29 Astellas Pharma Inc Chuo Ku Imidazole compounds and pharmaceutical compositions containing them
DE102004020186A1 (de) * 2004-04-22 2005-11-17 Aventis Pharma Deutschland Gmbh Heterocyclylessigsäuren als Inhibitoren von TAFla
US8710232B2 (en) 2004-04-22 2014-04-29 Sanofi-Aventis Deutschland Gmbh Imidazole derivatives used as TAFIa inhibitors

Also Published As

Publication number Publication date
EP2430002B1 (en) 2013-07-24
SI2430002T1 (sl) 2013-10-30
DK2430002T3 (da) 2013-11-04
CN102459192B (zh) 2015-06-24
JP2012526763A (ja) 2012-11-01
US20120245358A1 (en) 2012-09-27
RU2538506C2 (ru) 2015-01-10
IL216202A0 (en) 2012-01-31
HRP20130881T1 (hr) 2013-10-25
MY157304A (en) 2016-05-31
AU2010247431B2 (en) 2015-02-19
IL216202A (en) 2015-07-30
ES2431068T3 (es) 2013-11-25
WO2010130718A1 (en) 2010-11-18
AU2010247431A1 (en) 2011-12-01
KR20120016651A (ko) 2012-02-24
RS52963B (sr) 2014-02-28
SG176558A1 (en) 2012-01-30
CN102459192A (zh) 2012-05-16
JP5706397B2 (ja) 2015-04-22
CA2760748A1 (en) 2010-11-18
HK1168102A1 (en) 2012-12-21
PL2430002T3 (pl) 2013-12-31
EP2430002A1 (en) 2012-03-21
US8865906B2 (en) 2014-10-21
MX2011011849A (es) 2011-12-08
RU2011151044A (ru) 2013-06-20
PT2430002E (pt) 2013-09-11
BRPI1010571A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
CY1122670T1 (el) Παρασκευη παρασκευασματος και παρασκευασμα που περιλαμβανει αναστολεα μεκ
CY1125155T1 (el) Κρυσταλλικες μορφες αναστολεα προλυλο υδροξυλασης
CY1114493T1 (el) Διαδικασια για την παρασκευη μιας ενωσης χρησιμης ως αναστολεα της tafia
CY1123658T1 (el) Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης
CL2009000503A1 (es) Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida.
EA201590979A1 (ru) Способы и промежуточные химические соединения для получения фармацевтических средств
NI200900151A (es) Nuevo procedimiento de síntesis de la agomelatina.
BR112013006720A2 (pt) processo para preparação de inibidores de pan-cdk da fórmula (i) e intermediários da preparação
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
DK2285765T3 (da) Fremgangsmåde til fremstilling af derivater af 1-(2-halobiphenyl-4-yl)-cyclopropancarboxylsyre
NI200900153A (es) Nuevo procedimiento de síntesis de la agomelatina.
CY1116974T1 (el) Παραγωγα 5-υδροξυπυριμιδινο-4-καρβοξαμιδιου
MA32721B1 (fr) Composition pharmaceutique solide
MX2012001411A (es) Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico.
PY1115669A (es) Proceso para la preparación de amidas de ácido pirazolcarboxílico
UA114082C2 (xx) Спосіб одержання водорозчинних селеноглікопротеїнів та композиція, що їх містить
PY1115670A (es) Proceso para la preparación de amidas de ácido pirazolcarboxílico.
NI200900152A (es) Nuevo procedimiento de síntesis de la agomelatina
EA201270390A1 (ru) 1,2,4-триазин, который может быть использован в качестве ускорителя вулканизации, и способ его получения
NI200900154A (es) Nuevos procedimiento de obtención de la forma cristalina v de la agomelatina
EA200971019A1 (ru) Способы получения (r)-2-метилпирролидина и (s)-2-метилпирролидина и их солей винной кислоты
MX2013004193A (es) Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.
CY1112855T1 (el) Παραγωγα των πυρρολοπυριδινο-2-καρβοξαμιδιων, η παρασκευη τους και η θεραπευτικη εφαρμογη τους
UY31398A1 (es) Proceso para sintetizar compuestos de ácido fosfónico y posfínico
NI201300062A (es) Procedimiento e intermedios de síntesis de la agomelatina